Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy such as gemcitabine and irinotecan use different ways
to stop tumor cells from dividing so they stop growing or die. Combining more than one drug
may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving gemcitabine together with irinotecan
works in treating patients with cancer of unknown primary origin.